Author/Authors :
Patr?cia Montanheiro، نويسنده , , Ingrid Olah، نويسنده , , Ligia M.I. Fukumori، نويسنده , , Jerusa Smid، نويسنده , , Augusto César Penalva de Oliveira، نويسنده , , Luis I.B. Kanzaki، نويسنده , , Luiz Augusto M. Fonseca، نويسنده , , Alberto J.S. Duarte، نويسنده , , Jorge Casseb، نويسنده ,
Abstract :
HTLV-2 infections are almost always asymptomatic, and diseases associated with the infection are rarely reported. Little information is available on the relationship between HTLV-2 proviral load and gender or expression of disease, especially among patients with HIV-1 co-infection.
Methods
We studied 77 HTLV-2-infected subjects followed in our clinic for the last 9 years; 53 (69%) of them were co-infected with HIV-1. HTLV-2 DNA proviral load (PVL) was measured by real time PCR, a test with a sensitivity of 10 in 104 PBMCs.
Results
Six of 53 HTLV-2/HIV-1 cases had a myelopathy (all of them had undetectable PVL of HTLV-2). Only 3 of 35 women (2 out of 3 co-infected with HIV) had a detectable PVL, whereas 10 of 42 men had a detectable PVL. Regardless of their HIV status women had significantly lower PVL than men (10 vs. 43 copies/104 PBMCs, p < 0.05).
Conclusions
We noticed the occurrence of myelopathy in HTLV-2/HIV-1 co-infected patients, with undetectable HTLV-2 viral load. There was a sex difference in viral load for HTLV-2, what may be the result in mode of transmission or acquisition of the virus.
Keywords :
HTLV-2 , IDU , HIV-1- , transmission , DNA proviral load